Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Choose Topic

Optic nerve infiltration in primary central nervous system lymphoma

JAMA Neurology | Oct 29, 2017 Neurologic Oncology General Oncology

Prophylactic cholecystectomy at time of surgery for small bowel neuroendocrine tumor does not increase postoperative morbidity

Annals of Surgical Oncology | Oct 29, 2017 GI Oncology General Oncology

Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk

Journal of Gastroenterology and Hepatology | Oct 29, 2017 General Oncology Hepatobiliary/Pancreas

Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer

Cancer Chemotherapy and Pharmacology | Oct 29, 2017 Hepatobiliary/Pancreas Pharmacology/Therapy General Oncology

A non-randomized, open-label, single-arm, phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

Cancer Chemotherapy and Pharmacology | Oct 29, 2017 Pharmacology/Therapy GI Oncology General Oncology

Early breast cancer in the elderly: Characteristics, therapy, and long-term outcome

Oncology | Oct 29, 2017 Breast General Oncology

Efficacy and safety of capecitabine, irinotecan, gemcitabine, and bevacizumab as second-line treatment in advanced biliary tract cancer: A phase II study

Oncology | Oct 29, 2017 Pharmacology/Therapy Hepatobiliary/Pancreas General Oncology

Effectiveness of nivolumab versus docetaxel as second-line treatment in non-small cell lung cancer patients in clinical practice

Chemotherapy | Oct 29, 2017 Pharmacology/Therapy Lung/Thoracic Oncology General Oncology

Correlation between squamous cell carcinoma antigen level and the clinicopathological features of early-stage cervical squamous cell carcinoma and the predictive value of squamous cell carcinoma antigen combined with computed tomography scan for lymph node metastasis

International Journal of Gynecological Cancer | Oct 29, 2017 Diagnostics/Radiology Gynecologic Oncology General Oncology

Very-low-dose decitabine is effective in treating intermediate- or high-risk myelodysplastic syndrome

Acta Haematologica | Oct 29, 2017 Myeloproliferative Dz General Oncology

« Prev 1 … 1145 1146 1147 1148 1149 … 1255 Next »

Optic nerve infiltration in primary central nervous system lymphoma

Prophylactic cholecystectomy at time of surgery for small bowel neuroendocrine tumor does not increase postoperative morbidity

Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk

Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer

A non-randomized, open-label, single-arm, phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

Early breast cancer in the elderly: Characteristics, therapy, and long-term outcome

Efficacy and safety of capecitabine, irinotecan, gemcitabine, and bevacizumab as second-line treatment in advanced biliary tract cancer: A phase II study

Effectiveness of nivolumab versus docetaxel as second-line treatment in non-small cell lung cancer patients in clinical practice

Correlation between squamous cell carcinoma antigen level and the clinicopathological features of early-stage cervical squamous cell carcinoma and the predictive value of squamous cell carcinoma antigen combined with computed tomography scan for lymph node metastasis

Very-low-dose decitabine is effective in treating intermediate- or high-risk myelodysplastic syndrome

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Optic nerve infiltration in primary central nervous system lymphoma

Prophylactic cholecystectomy at time of surgery for small bowel neuroendocrine tumor does not increase postoperative morbidity

Individual and combined effects of hepatitis B surface antigen level and viral load on liver cancer risk

Phase II study of fixed dose-rate gemcitabine plus S-1 as a second-line treatment for advanced biliary tract cancer

A non-randomized, open-label, single-arm, phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer

Early breast cancer in the elderly: Characteristics, therapy, and long-term outcome

Efficacy and safety of capecitabine, irinotecan, gemcitabine, and bevacizumab as second-line treatment in advanced biliary tract cancer: A phase II study

Effectiveness of nivolumab versus docetaxel as second-line treatment in non-small cell lung cancer patients in clinical practice

Correlation between squamous cell carcinoma antigen level and the clinicopathological features of early-stage cervical squamous cell carcinoma and the predictive value of squamous cell carcinoma antigen combined with computed tomography scan for lymph node metastasis

Very-low-dose decitabine is effective in treating intermediate- or high-risk myelodysplastic syndrome

Awareness for COPD: MCQ challenge

BRI or BMI: What is More Efficient?

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Select Specialty

Select Topic